Nano-X Imaging Ltd

NNOX remains in a Stage 4 decline with confirmed lower highs and lower lows under declining EMAs. The recent volume-backed bounce from extreme oversold conditions has provided relief but not reversed the downtrend. Price is extended below the 9/21/50-day EMA cluster, and the speculative approach favors trimming into rallies toward these overhead EMAs rather than initiating new shorts at current levels.

• ↑Q1 revenue up 54% YoY to $4.3M, driven by teleradiology services
• ↑360 signed deployment agreements signal multi-year growth potential
• ↓Net loss widened to $14.3M in Q1, with a $2.6M gross loss